Quarterly report pursuant to Section 13 or 15(d)

Summary Significant Accounting Policies Parentheticals (Details)

v2.4.0.8
Summary Significant Accounting Policies Parentheticals (Details) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Summary Significant Accounting Policies Parentheticals    
Amortization of deferred financing costs related to convertible debt $ 4,835  
Research Expenses - Salaries and equipment related expenses   25,000
Clinical Studies expenses - fees, charges and related expenses 391,000 104,000
Compensation expenses recorded 22,372 6,037
Cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to 250,000  
The remainder of the cost of the patents related to its former product written off in the amount 6,234  
Advertising and Public Relations costs are charged to operations when incurred 12,853 7,461
Common stock warrants were granted to the CFO for services rendered 50,000 50,000
Value of Common stock warrants were granted to the CFO for services rendered $ 7,228 $ 15,144